Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 10:25 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.
View All Commentary (ENZN)
Recs
LarkinSoft (96.66) Submitted: 10/09/06 7:45 PM : Start Price: $8.21 ENZN Score: 10.63
Nearly 100% of the stock is in the hands of institutional traders, all purchased near the bottom. Riding the smart money's coattails is a sure winner. This stock will double within 24 months.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK